TY - JOUR
T1 - Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Patients Aged 70 Years or Older
AU - Biancari, Fausto
AU - Saeed, Diyar
AU - Fiore, Antonio
AU - Dalén, Magnus
AU - Ruggieri, Vito G.
AU - Jónsson, Kristján
AU - Gatti, Giuseppe
AU - Zipfel, Svante
AU - Dell'Aquila, Angelo M.
AU - Chocron, Sidney
AU - Bounader, Karl
AU - Amr, Gilles
AU - Settembre, Nicla
AU - Pälve, Kristiina
AU - Loforte, Antonio
AU - Gabrielli, Marco
AU - Livi, Ugolino
AU - Lechiancole, Andrea
AU - Pol, Marek
AU - Netuka, Ivan
AU - Spadaccio, Cristiano
AU - Pettinari, Matteo
AU - De Keyzer, Dieter
AU - Reichart, Daniel
AU - Ragnarsson, Sigurdur
AU - Alkhamees, Khalid
AU - Lichtenberg, Artur
AU - Fux, Thomas
AU - El Dean, Zein
AU - Fiorentino, Mariafrancesca
AU - Mariscalco, Giovanni
AU - Jeppsson, Anders
AU - Welp, Henryk
AU - Perrotti, Andrea
PY - 2019
Y1 - 2019
N2 - Background: There is uncertainty whether venoarterial extracorporeal membrane oxygenation (VA-ECMO) should be used in older patients with cardiopulmonary failure after cardiac surgery. Methods: This was a retrospective multicenter study of 781 patients who required postcardiotomy VA-ECMO for cardiopulmonary failure after adult cardiac surgery from 2010 to 2018 at 19 cardiac surgery centers. A parallel systematic review with meta-analysis of the literature was performed. Results: The hospital mortality in the overall Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation (PC-ECMO) series was 64.4%. A total of 255 patients were 70 years old or older (32.7%), and their hospital mortality was significantly higher than in younger patients (76.1% vs 58.7%; adjusted odds ratio, 2.199; 95% confidence interval [CI], 1.536 to 3.149). Arterial lactate level greater than 6 mmol/L before starting VA-ECMO was the only predictor of hospital mortality among patients 70 years old or older in univariate analysis (82.6% vs 70.4%; P =.029). Meta-analysis of current and previous studies showed that early mortality after postcardiotomy VA-ECMO was significantly higher in patients aged 70 years or older compared with younger patients (odds ratio, 2.09; 95% CI, 1.59 to 2.75; 5 studies including 1547 patients; I2, 5.9%). The pooled early mortality rate among patients aged 70 years or older was 78.8% (95% CI, 74.1 to 83.5; 6 studies including 617 patients; I2, 41.8%). Two studies reported 1-year mortality (including hospital mortality) of 79.9% and 75.6%, respectively, in patients 70 years old or older. Conclusions: Advanced age should not be considered a contraindication for postcardiotomy VA-ECMO. However, in view of the high risk of early mortality, meaningful scrutiny is needed before using VA-ECMO after cardiac surgery in older patients.
AB - Background: There is uncertainty whether venoarterial extracorporeal membrane oxygenation (VA-ECMO) should be used in older patients with cardiopulmonary failure after cardiac surgery. Methods: This was a retrospective multicenter study of 781 patients who required postcardiotomy VA-ECMO for cardiopulmonary failure after adult cardiac surgery from 2010 to 2018 at 19 cardiac surgery centers. A parallel systematic review with meta-analysis of the literature was performed. Results: The hospital mortality in the overall Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation (PC-ECMO) series was 64.4%. A total of 255 patients were 70 years old or older (32.7%), and their hospital mortality was significantly higher than in younger patients (76.1% vs 58.7%; adjusted odds ratio, 2.199; 95% confidence interval [CI], 1.536 to 3.149). Arterial lactate level greater than 6 mmol/L before starting VA-ECMO was the only predictor of hospital mortality among patients 70 years old or older in univariate analysis (82.6% vs 70.4%; P =.029). Meta-analysis of current and previous studies showed that early mortality after postcardiotomy VA-ECMO was significantly higher in patients aged 70 years or older compared with younger patients (odds ratio, 2.09; 95% CI, 1.59 to 2.75; 5 studies including 1547 patients; I2, 5.9%). The pooled early mortality rate among patients aged 70 years or older was 78.8% (95% CI, 74.1 to 83.5; 6 studies including 617 patients; I2, 41.8%). Two studies reported 1-year mortality (including hospital mortality) of 79.9% and 75.6%, respectively, in patients 70 years old or older. Conclusions: Advanced age should not be considered a contraindication for postcardiotomy VA-ECMO. However, in view of the high risk of early mortality, meaningful scrutiny is needed before using VA-ECMO after cardiac surgery in older patients.
U2 - 10.1016/j.athoracsur.2019.04.063
DO - 10.1016/j.athoracsur.2019.04.063
M3 - Review article
C2 - 31185202
AN - SCOPUS:85071612281
SN - 0003-4975
VL - 108
SP - 1257
EP - 1264
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 4
ER -